Andrew K. Balo - Insider Trading & Ownership

Location
C/O Dexcom, Inc., 5555 Oberlin Drive, San Diego, CA
Summary
The estimated net worth of Andrew K. Balo is at least $10.1M dollars as of March 28, 2025. Andrew K. Balo is the EVP Regulatory Strategy Clinic of DEXCOM INC and owns shares of DEXCOM INC (DXCM) stock worth about $10M. Andrew K. Balo is the Director of Glucotrack, Inc. and owns shares of Glucotrack, Inc. (GCTK) stock worth about $22.9K.
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Andrew K. Balo

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DXCM DEXCOM INC EVP Regulatory Strategy Clinic $10M Mar 10, 2023
GCTK Glucotrack, Inc. Director $22.9K Mar 26, 2025

Insider Transactions Reported by Andrew K. Balo:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.